Skip to content

The efficacy of ab interno canaloplasty (ABiC) combined with phacoemulsification on primary open angle glaucoma (POAG)

The efficacy of ab interno canaloplasty (ABiC) combined with phacoemulsification on primary open angle glaucoma (POAG)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016557
Enrollment
Unknown
Registered
2018-06-08
Start date
2018-06-11
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Case series:ABiC combined with phacoemulsification

Sponsors

Eye Center of Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Male or female patients, 18-80 years of age, diagnosed with POAG combined with cataract, unable to control IOP or intolerant with local anti-glaucoma medications were enrolled. Patients were schedule to undergo ABiC combined with phacoemulsification.

Exclusion criteria

Exclusion criteria: Patients with allergy to any of the study medications, history of ocular trauma or any intraocular operation, narrow angle (Schaffer III or IV), secondary glaucoma, optic nerve atrophy due to other causes, or history of serious systemic disease were excluded. Patients who were initially included were excluded if they had intraoperative or severe postoperative complications. Women who were pregnant or lactating were not permitted to be in the study.

Design outcomes

Primary

MeasureTime frame
IOP;anti-glaucoma medication;

Secondary

MeasureTime frame
vision field;vision acuity;

Countries

China

Contacts

Public ContactKe Yao

Eye Center of Second Affiliated Hospital of Zhejiang University School of Medicine

xlren@zju.edu.cn+86 13906517262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026